Impacting Sepsis Outcomes Using MALDI-TOF: FDA-Cleared Application for Rapid Microbial ID Direct from Positive Blood Culture

During this webinar we will present the Lahey four-year journey of using the MBT Sepsityper^® solution for the rapid identification (ID) of microorganisms direct from positive blood culture (PBC). The focus will be on the recent implementation of the MBT Sepsityper Kit US IVD, the only FDA cleared MALDI-TOF based application available for rapid ID direct from PBC, in the clinical microbiology laboratory at Lahey Hospital and Medical Center. The presentation will discuss 1) the ease and benefits of implementing an FDA-cleared application, 2) how the MBT Sepsityper^® workflow can be used as a rapid front-line method to identify a broad range of microorganisms, 3) how to decrease the use of expensive molecular applications on the blood culture bench with workflow suggestions, and 4) present actual case studies that demonstrate the clinical impact of a rapid ID direct from PBC using MBT Sepsityper^® workflow. Finally in closing, please join the Q & A session where you can ask Felicia, a proven MBT Sepsityper expert, questions that you may have.

 

Learning Objectives

Only for sale in the United States and Puerto Rico.